Trial Profile
Clinical Trials Insight: 700049208
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2009
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 26 Sep 2009 New trial record.